Catabasis Pharms

CATB NASDAQ
7.61
+0.02
+0.24%
交易中 13:46 06/24 EDT
开盘
8.10
昨收
7.59
最高
8.14
最低
7.53
成交量
11.05万
成交均量(3M)
13.07万
52周最高
10.40
52周最低
3.600
换手率
0.96%
市值
8,748.59万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Catabasis Pharms CATB股票价格,Catabasis Pharms股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Catabasis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted (SMART), a linker drug discovery platform. The SMART linker drug discovery platform enables to engineer product candidates that can modulate multiple targets in a disease. The Company's primary focus is on treatments for rare diseases. The Company is also developing other product candidates for the treatment of lipid disorders. The Company's CAT-1004 is a SMART linker conjugate of salicylate, a non-steroidal anti-inflammatory drug, and the omega-3 fatty acid docosahexaenoic acid (DHA), a naturally occurring unsaturated fatty acid with anti-inflammatory properties. Its CAT-2000 series product candidates inhibit the Sterol Regulatory Element Binding Protein (SREBP) pathway. The Company's CAT-4001 is a SMART linker conjugate of monomethyl fumarate and DHA.
展开 >

最近浏览

名称
价格
涨跌幅